InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Pops Richard F, 首席执行官. Insider active across 2 companies, notably Alkermes plc.. In total, 18 disclosures have been logged. Activity tracked since 6 May 2021. The latest transaction was disclosed on 22 May 2025 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pops Richard F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
149,580 股Ordinary SharesSEC:0001520262-26-000019:0
2,869 股0Common StockSEC:0000914475-25-000129:0
190,640 股Ordinary SharesSEC:0001127602-25-003685:0
4,199 股0Common StockSEC:0000914475-24-000136:0
23,200 股@ US$42.7665.7% 占其流量Common StockSEC:0000914475-24-000092:0
1,700 股@ US$42.764.8% 占其流量Common StockSEC:0000914475-24-000088:0
15,000 股@ US$12.9813.1% 占其流量Common StockSEC:0000914475-24-000078:0
218,551 股Ordinary SharesSEC:0001127602-24-004634:0
119,713 股Ordinary SharesSEC:0001127602-23-006518:0
15,000 股@ US$12.7112.9% 占其流量Common StockSEC:0001209191-23-002053:0
7,500 股@ US$6.660.0003% mcap100.0% 占其流量Common StockSEC:0001209191-22-028369:0
329,153 股@ US$16.550.11% mcap30.3% 占其流量Ordinary SharesSEC:0001127602-22-013707:0
32,400 股Ordinary SharesSEC:0001127602-22-006324:0
18,125 股Ordinary SharesSEC:0001127602-22-005452:0
81,682 股0Ordinary SharesSEC:0001127602-21-025409:0
150,000 股@ US$18.10520.0% 占其流量Ordinary SharesSEC:0001127602-21-017397:0
150,000 股@ US$18.10520.1% 占其流量Ordinary SharesSEC:0001127602-21-016394:0
100,000 股@ US$18.10513.5% 占其流量Ordinary SharesSEC:0001127602-21-015894:0
18 条申报中的 18 条
About Pops Richard F
POPS RICHARD F is Directeur Général. He has 18 filings in total, and across the 18 recent sampled filings, the most frequent transaction nature is option exercise. The sampled filings cover the period from 2021-05-07 to 2026-02-06, with buy amounts of EUR 0 and sell amounts of EUR 0. He is listed at Alkermes plc. as Director and CEO, Alkermes plc, and at Neurocrine Biosciences INC as Director.
